Search

Your search for "Trxade" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Strategic Board Appointment of Leading Pharmaceutical Industry Expert

August 16, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the appointment of Jeff Newell to the company’s advisory board. Newell is expected to serve as a strategic resource to TRxADE as it continues […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Releases Q2 Financial Report Showing Revenue Growth

July 26, 2022

TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its second-quarter 2022 financial and operational information, for the period ended June 30, 2022. According to the report, revenues for Q2 2022 increased 73%, totaling […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Integra Pharma Partners with Pharmaceutical Co. to Help Network Members Succeed

July 13, 2022

TRxADE Health (NASDAQ: MEDS), through its wholly owned pharmaceutical wholesale business, Integra Pharma Solutions LLC, has inked a distribution agreement with GALT Pharmaceuticals LLC. Integra currently distributes generic and brand medications directly in 34 states through its warehouse; the new partnership adds single-source and multisource products directly from GALT Pharmaceuticals to its offering, supporting Integra’s mission […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Upcoming Earnings Call

July 12, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning on releasing its financial information for Q2 2022 after the market closes on July 25, 2022. The company announced that it will release the […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Health Inc.’s (NASDAQ: MEDS) Bonum Health Unveils Televeterinary Services

May 19, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has partnered with its digital healthcare subsidiary Bonum Health to announce a new service: televeterinary services for pets. According to the announcement, Bonum Health, which provides […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Q1 2022 Financial Numbers, Operational Highlights

May 10, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has released its first quarter 2022 financial results. Highlights of the report, which covers the period ended March 31, 2022, include revenues for the period totaling […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Announces Plans to Release Q1 2022 Financial Numbers

April 25, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will release its financial results for first quarter 2022 on May 9, 2022; a press release with the financial report will be released after the market […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Health Inc. (NASDAQ: MEDS) Release Fourth-Quarter, Year-End Financial Results

March 29, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its Q4 and fiscal year 2021 numbers. The company also reported operational highlights and noted that in 2022 it is continuing a strategic  nationwide […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) to Release Fourth-Quarter, Year-End Financial Results

March 15, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced it will report its financial results for Q4 and year end 2021 later this month. The company said it will release the information on […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Subsidiary Partners with Grocery Chain to Provide Deeply Discounted Telemedicine to Uninsured, Underinsured Customers

February 23, 2022

TRxADE Group (NASDAQ: MEDS), an integrated drug procurement, delivery, healthcare platform and health service company, through its subsidiary Bonum Health, has signed a deal with Coborn’s Inc. for discount telemedicine services. TRxADE will work with Coborn’s, a regional grocery chain with more than 120 food and pharmacy grocery stores located throughout the Midwest, to provide affordable […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS), Exchange Health LLC Collaborate to Form SOSRx.com

February 15, 2022

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the formation with Exchange Health LLC of a joint venture, SOSRx LLC, a pharmaceutical platform. According to the update, SOSRx will provide pharmaceutical manufacturers […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Announces Participation in Aegis Virtual Conference

February 10, 2022

TRxADE Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be participating in the upcoming Aegis Capital Corp. Virtual Conference this month. The three-day conference is slated for Feb. 23–25, 2022. MEDS CEO Suren Ajjarapu […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Resumes Modified Stock Repurchase Program

December 13, 2021

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that its board of directors has authorized the resumption of the previously disclosed stock repurchase program, which the board modified to allow for the […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Launch of T-Rx(TM) Savings Card

November 30, 2021

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced the launch of its TRxADE Discount Card. The new offering empowers independent pharmacies to continue providing their customers with deeply discounted drug pricing while […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) to Participate in Upcoming LD Micro Movers Virtual Event

November 18, 2021

TRxADE Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the LD Micro Movers Virtual Event. The virtual event, which focuses on notable small-cap companies of 2021, will take place Dec. 1, 2021. […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Group Inc. (NASDAQ: MEDS) Releases Q3 2021 Financial Report

October 26, 2021

TRxADE Group (NASDAQ: MEDS),a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial numbers for quarter three 2021, the period ended Sept. 30, 2021. Highlights of the report include a revenue increase of 34.3% over Q2 […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Planned Release of Q3 2021 Financial Results

October 11, 2021

TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that it will release financial results for the third quarter of 2021 after market close on Oct. 25, 2021. According to the update, management […]

InvestorNewsBreaks

InvestorNewsBreaks – TRxADE HEALTH INC.’s (NASDAQ: MEDS) Bonum Health Launches eGift Card Program

August 10, 2021

TRxADE HEALTH (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that its telehealth subsidiary, Bonum Health, has launched an electronic gift card program as an innovative new way for uninsured and under-insured consumers to gain access to health care. Bonum Health’s electronic gift cards (Bonum Health eGift(TM)) are pre-paid digital […]

News Articles

TRxADE HEALTH, INC. (NASDAQ: MEDS) Featured in Virtual Coverage of LD Micro’s Invitational XI

June 7, 2021

TRxADE HEALTH, INC. (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,100+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Name Change to Reflect New Mission, Strategic Direction

May 28, 2021

Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., today announced that the company will be changing its name to TRxADE Health Inc. The change, effective Tuesday, June 1, 2021, reflects the company’s new mission […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Present at Virtual Planet MicroCap Showcase

April 19, 2021

Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, will be presenting at the upcoming Planet MicroCap Showcase. Scheduled to take place on April 20–22, 2021, the virtual Planet MicroCap event will feature 66 small-cap, […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Planned Release of Q1 2021 Financial Results, Conference Call

April 13, 2021

Trxade Group (NASDAQ: MEDS),a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will its first-quarter 2021 financial results after market close on April 26, 2021. As part of that release, the company has scheduled a […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Planet MicroCap Showcase

April 9, 2021

Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience, today announced that management will present at the Planet MicroCap Showcase, which is scheduled to take place virtually April 20-22, 2021. According to the update, Suren Ajjarapu, TRxADE Group’s chairman and chief executive officer, is scheduled to host a […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Quarter, FY 2020 Financial Report

March 30, 2021

Trxade Group (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial results for fourth quarter and fiscal year for the period ended Dec. 31, 2020. The report also included key operational highlights. Financial […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Schedules Call, Will Release Q4 and FY 2020 Financial Results

March 16, 2021

Trxade Group (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has announced that it will report Q4 and FY 2020 financial results. MEDS will release the numbers, which are for the fourth quarter and fiscal year ended Dec. […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Participation in Upcoming Investor Conferences

March 5, 2021

Trxade Group (NASDAQ: MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, will be participating in three investor conferences scheduled in March 2021. In all three conferences, Trxade Group CEO Suren Ajjarapu will present valuable information and insights about the company for conference participants. In addition, he is scheduled to participate in one-on-one […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Postpone February Virtual Road Show

February 2, 2021

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, has announced that it will postpone its upcoming virtual road show. Trxade had previously announced that the road show event would be held Wednesday, Feb. 3, 2021, at 11 a.m. ET. The company, which operates across the United States in all 50 states, will reschedule […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Slated to Host February Virtual Roadshow

January 20, 2021

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has announced that it will be hosting a virtual roadshow next month. The event is scheduled for 11 a.m. ET on Wednesday, Feb. 3, 2021. Trxade Group CEO Suren Ajjarapu will host the presentation, which will include an overview of the company’s business model […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Partners with KPH Healthcare Service to Provide Telehealth Services

December 10, 2020

Trxade Group (NASDAQ: MEDS), through its telehealth subsidiary Bonum Health, has signed a strategic agreement with KPH Healthcare Services (“KPH”), a leading pharmaceutical and healthcare services provider, to provide affordable telemedicine services to two KPH divisions. Trxade, an integrated drug procurement, delivery and healthcare platform, will work through Bonum to serve the patients of approximately 100 […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Launch of Trxade Prime Purchasing Solution

December 8, 2020

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced the launch of Trxade Prime, a revolutionary service offered by the company’s Integra Pharma Solutions subsidiary. According to the update, Trxade Prime solves a historic problem for independent pharmacies suffering from an already complex prescription distribution process. The solution allows […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Platform Meets Today’s Demands Through Intelligent Design

November 25, 2020

Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health care platform, is ideally situated as the global pandemic has led to a cascade of changes involving how health care is administered, perhaps most notably in the increased adoption of telehealth services. Trxade Group’s business model appears to aptly and effectively meet today’s demands, largely […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Host Virtual Presentation at Diamond Equity Research Emerging Growth Invitational

November 18, 2020

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational. According to the update, the investor conference is scheduled to take place virtually on Dec. 1, 2020. Trxade Group CEO Suren Ajjarapu will, beginning at 3:40 p.m. Eastern […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Plans to Present at Virtual Fall Investor Summit

November 11, 2020

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced that management will present at the Virtual Fall Investor Summit, hosted by Investor Summit Group and taking place November 16-18, 2020. According to the update, Trxade CEO Suren Ajjarapu is scheduled to participate in one-on-one meetings throughout the event and […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Q3 2020 Financials, Marks Record Numbers

October 28, 2020

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform,has released financial numbers for its third quarter. Financial highlights include third-quarter revenues up by 174% to $6.3 million, compared to revenue of $2.3 million in the same quarter last year; third-quarter gross profit increased 47% to $1.9 million, compared to gross profit of $1.3 […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Announce Q3 2020 Results, Host Conference Call

October 27, 2020

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, October 26, 2020. According to the update, Trxade management will host a conference call to discuss the results at 5:00 p.m. Eastern Time on Monday, October […]

InvestorNewsBreaks

InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Digital Spotlight on Telehealth Services, Smart Technology

October 21, 2020

Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, was showcased at several recent virtual conferences and events. In a realm not limited by location, the company’s leadership took advantage of the opportunity to boost exposure of Trxade’s innovative platform and solutions to potential investors. Among capabilities highlighted in the digital spotlight, Trxade’s […]

InvestorNewsBreaks

InvestorNewsBreaks – Investor Summit Group Releases Lineup of 77 Public Companies to Present at Virtual Fall Event

November 13, 2020

The Investor Summit Group on Thursday released further details for its Virtual Fall Summit, which is slated to take place from Nov. 16-18, 2020. The event will connect 77 presenting small and microcap companies with distinguished investors from around the globe. Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: […]

Press Releases

77 Public Companies to present at the Virtual Fall Investor Summit on November 16th-18th

November 12, 2020

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) — via InvestorWire — The Virtual Summer Summit will take place on November 16th-18th, connecting 77 presenting small and microcap companies with distinguished investors from around the globe. A full list of issuers are listed below along with webcasting links to view presentations. Company Ticker Webcast URL Actinium Pharmaceuticals ATNM […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).